{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:19:14Z","timestamp":1794201554683,"version":"4.8.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s12012-022-09727-9","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T08:02:53Z","timestamp":1644998573000},"page":"254-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardiac Complications: The Understudied Aspect of Cancer Cachexia"],"prefix":"10.1007","volume":"22","author":[{"given":"Vivek","family":"Bora","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0594-5452","authenticated-orcid":false,"given":"Bhoomika","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"issue":"1","key":"9727_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.5935\/ABC.20160142","volume":"108","author":"MP Okoshi","year":"2017","unstructured":"Okoshi, M. P., Capalbo, R. V., Romeiro, F. G., & Okoshi, K. (2017). Cardiac cachexia: Perspectives for prevention and treatment. Arquivos Brasileiros de Cardiologia, 108(1), 74. https:\/\/doi.org\/10.5935\/ABC.20160142","journal-title":"Arquivos Brasileiros de Cardiologia"},{"key":"9727_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","volume":"143","author":"J Jankowski","year":"2021","unstructured":"Jankowski, J., Floege, J., Fliser, D., B\u00f6hm, M., & Marx, N. (2021). Cardiovascular disease in chronic kidney disease. Circulation, 143, 1157\u20131172. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050686","journal-title":"Circulation"},{"issue":"2","key":"9727_CR3","doi-asserted-by":"publisher","first-page":"152","DOI":"10.2174\/1570159X18666200729093724","volume":"19","author":"J Leszek","year":"2021","unstructured":"Leszek, J., Mikhaylenko, E. V., Belousov, D. M., Koutsouraki, E., Szczechowiak, K., Kobusiak-Prokopowicz, M., & Aliev, G. (2021). The links between cardiovascular diseases and Alzheimer\u2019s disease. Current Neuropharmacology, 19(2), 152. https:\/\/doi.org\/10.2174\/1570159X18666200729093724","journal-title":"Current Neuropharmacology"},{"key":"9727_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/S43094-020-00151-W","author":"A Sharma","year":"2020","unstructured":"Sharma, A., Mittal, S., Aggarwal, R., & Chauhan, M. K. (2020). Diabetes and cardiovascular disease: Inter-relation of risk factors and treatment. Future Journal of Pharmaceutical Sciences. https:\/\/doi.org\/10.1186\/S43094-020-00151-W","journal-title":"Future Journal of Pharmaceutical Sciences"},{"issue":"12","key":"9727_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/CANCERS12123737","volume":"12","author":"KJ Ruddy","year":"2020","unstructured":"Ruddy, K. J., Patel, S. R., Higgins, A. S., Armenian, S. H., & Herrmann, J. (2020). Cardiovascular health during and after cancer therapy. Cancers, 12(12), 1\u201316. https:\/\/doi.org\/10.3390\/CANCERS12123737","journal-title":"Cancers"},{"key":"9727_CR6","doi-asserted-by":"publisher","DOI":"10.15420\/ECR.2020.44","author":"AM Kerola","year":"2021","unstructured":"Kerola, A. M., Rollefstad, S., & Semb, A. G. (2021). Atherosclerotic cardiovascular disease in rheumatoid arthritis: Impact of inflammation and antirheumatic treatment. European Cardiology Review. https:\/\/doi.org\/10.15420\/ECR.2020.44","journal-title":"European Cardiology Review"},{"key":"9727_CR7","doi-asserted-by":"publisher","DOI":"10.1139\/CJPP-2021-0012","author":"V Bora","year":"2021","unstructured":"Bora, V., Patel, D., Johar, K., Goyal, R. K., & Patel, B. M. (2021). Systemic study of selected HDAC inhibitors in cardiac complications associated with cancer cachexia. Canadian Journal of Physiology and Pharmacology. https:\/\/doi.org\/10.1139\/CJPP-2021-0012","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"issue":"4","key":"9727_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.smhs.2020.10.003","volume":"2","author":"S Lim","year":"2020","unstructured":"Lim, S., Brown, J. L., Washington, T. A., & Greene, N. P. (2020). Development and progression of cancer cachexia: Perspectives from bench to bedside. Sports Medicine and Health Science, 2(4), 177\u2013185. https:\/\/doi.org\/10.1016\/j.smhs.2020.10.003","journal-title":"Sports Medicine and Health Science"},{"key":"9727_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00288-6","author":"V Rausch","year":"2021","unstructured":"Rausch, V., Sala, V., Penna, F., Porporato, P. E., & Ghigo, A. (2021). Understanding the common mechanisms of heart and skeletal muscle wasting in cancer cachexia. Oncogenesis. https:\/\/doi.org\/10.1038\/s41389-020-00288-6","journal-title":"Oncogenesis"},{"issue":"5","key":"9727_CR10","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3892\/or.2017.5542","volume":"37","author":"Y Belloum","year":"2017","unstructured":"Belloum, Y., Rannou-Bekono, F., & Favier, F. B. (2017). Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity (Review). Oncology Reports, 37(5), 2543\u20132552. https:\/\/doi.org\/10.3892\/or.2017.5542","journal-title":"Oncology Reports"},{"issue":"1","key":"9727_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/J.HFC.2019.08.006","volume":"16","author":"M Valentova","year":"2020","unstructured":"Valentova, M., Anker, S. D., & von Haehling, S. (2020). Cardiac cachexia revisited: The role of wasting in heart failure. Heart Failure Clinics, 16(1), 61\u201369. https:\/\/doi.org\/10.1016\/J.HFC.2019.08.006","journal-title":"Heart Failure Clinics"},{"key":"9727_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.116713","volume":"233","author":"H Memon","year":"2019","unstructured":"Memon, H., & Patel, B. M. (2019). Immune checkpoint inhibitors in non-small cell lung cancer\u202f: A bird \u2019 s eye view. Life Sciences, 233, 116713. https:\/\/doi.org\/10.1016\/j.lfs.2019.116713","journal-title":"Life Sciences"},{"key":"9727_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/FCVM.2021.619650","author":"S Xu","year":"2021","unstructured":"Xu, S., Sharma, U. C., Tuttle, C., & Pokharel, S. (2021). Immune checkpoint inhibitors: Cardiotoxicity in pre-clinical models and clinical studies. Frontiers in Cardiovascular Medicine. https:\/\/doi.org\/10.3389\/FCVM.2021.619650","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"1","key":"9727_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.15420\/CFR.2017:3:2","volume":"3","author":"M Sweeney","year":"2017","unstructured":"Sweeney, M., Yiu, A., & Lyon, A. R. (2017). Cardiac atrophy and heart failure in cancer. Cardiac Failure Review, 3(1), 62. https:\/\/doi.org\/10.15420\/CFR.2017:3:2","journal-title":"Cardiac Failure Review"},{"issue":"2","key":"9727_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13539-014-0137-y","volume":"5","author":"SMR Kazemi-Bajestani","year":"2014","unstructured":"Kazemi-Bajestani, S. M. R., Becher, H., Fassbender, K., Chu, Q., & Baracos, V. E. (2014). Concurrent evolution of cancer cachexia and heart failure: Bilateral effects exist. Journal of Cachexia, Sarcopenia and Muscle, 5(2), 95\u2013104. https:\/\/doi.org\/10.1007\/s13539-014-0137-y","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"key":"9727_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/FPHYS.2021.729713","author":"D Finke","year":"2021","unstructured":"Finke, D., Heckmann, M. B., Frey, N., & Lehmann, L. H. (2021). Cancer-a major cardiac comorbidity with implications on cardiovascular metabolism. Frontiers in physiology. https:\/\/doi.org\/10.3389\/FPHYS.2021.729713","journal-title":"Frontiers in physiology"},{"issue":"4","key":"9727_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/ehf2.12184","volume":"4","author":"A Barkhudaryan","year":"2017","unstructured":"Barkhudaryan, A., Scherbakov, N., Springer, J., & Doehner, W. (2017). Cardiac muscle wasting in individuals with cancer cachexia. ESC Heart Failure, 4(4), 458\u2013467. https:\/\/doi.org\/10.1002\/ehf2.12184","journal-title":"ESC Heart Failure"},{"issue":"5","key":"9727_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1378\/CHEST.54.5.403","volume":"54","author":"GE Burch","year":"1968","unstructured":"Burch, G. E., Phillips, J. H., & Ansari, A. (1968). The cachetic heart. A clinico-pathologic, electrocardiographic and roentgenographic entity. Diseases of the Chest, 54(5), 403\u2013409. https:\/\/doi.org\/10.1378\/CHEST.54.5.403","journal-title":"Diseases of the Chest"},{"issue":"1","key":"9727_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1006\/ABBI.1993.1479","volume":"306","author":"L Tessitore","year":"1993","unstructured":"Tessitore, L., Costelli, P., Bonetti, G., & Baccino, F. M. (1993). Cancer cachexia, malnutrition, and tissue protein turnover in experimental animals. Archives of Biochemistry and Biophysics, 306(1), 52\u201358. https:\/\/doi.org\/10.1006\/ABBI.1993.1479","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"5","key":"9727_CR20","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.3892\/ijo.2011.1150","volume":"39","author":"M Tian","year":"2011","unstructured":"Tian, M., Asp, M. L., Nishijima, Y., & Belury, M. A. (2011). Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice. International Journal of Oncology, 39(5), 1321\u20131326. https:\/\/doi.org\/10.3892\/ijo.2011.1150","journal-title":"International Journal of Oncology"},{"issue":"6","key":"9727_CR21","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3892\/ijo.2013.1893","volume":"42","author":"NDPK Manne","year":"2013","unstructured":"Manne, N. D. P. K., Lima, M., Enos, R. T., Wehner, P., Carson, J. A., & Blough, E. (2013). Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin\/+ mouse. International Journal of Oncology, 42(6), 2134\u20132140. https:\/\/doi.org\/10.3892\/ijo.2013.1893","journal-title":"International Journal of Oncology"},{"issue":"2","key":"9727_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3892\/IJO_00000683","volume":"37","author":"M Tian","year":"2010","unstructured":"Tian, M., Nishijima, Y., Asp, M. L., Stout, M. B., Reiser, P. J., & Belury, M. A. (2010). Cardiac alterations in cancer-induced cachexia in mice. International Journal of Oncology, 37(2), 347\u2013353. https:\/\/doi.org\/10.3892\/IJO_00000683","journal-title":"International Journal of Oncology"},{"issue":"5","key":"9727_CR23","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1158\/0008-5472.CAN-10-3145","volume":"71","author":"PF Cosper","year":"2011","unstructured":"Cosper, P. F., & Leinwand, L. A. (2011). Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Research, 71(5), 1710\u20131720. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3145","journal-title":"Cancer Research"},{"issue":"9\u201310","key":"9727_CR24","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.lfs.2010.12.010","volume":"88","author":"H Xu","year":"2011","unstructured":"Xu, H., Crawford, D., Hutchinson, K. R., Youtz, D. J., Lucchesi, P. A., Velten, M., & Wold, L. E. (2011). Myocardial dysfunction in an animal model of cancer cachexia. Life Sciences, 88(9\u201310), 406\u2013410. https:\/\/doi.org\/10.1016\/j.lfs.2010.12.010","journal-title":"Life Sciences"},{"issue":"3","key":"9727_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ajpath.2010.12.009","volume":"178","author":"A Wysong","year":"2011","unstructured":"Wysong, A., Couch, M., Shadfar, S., Li, L., Rodriguez, J. E., Asher, S., & Willis, M. S. (2011). NF-\u03baB inhibition protects against tumor-induced cardiac atrophy in vivo. American Journal of Pathology, 178(3), 1059\u20131068. https:\/\/doi.org\/10.1016\/j.ajpath.2010.12.009","journal-title":"American Journal of Pathology"},{"issue":"14","key":"9727_CR26","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/eurheartj\/eht302","volume":"35","author":"J Springer","year":"2014","unstructured":"Springer, J., Tschirner, A., Haghikia, A., Von Haehling, S., Lal, H., Grzesiak, A., & Anker, S. D. (2014). Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. European Heart Journal, 35(14), 932\u2013941. https:\/\/doi.org\/10.1093\/eurheartj\/eht302","journal-title":"European Heart Journal"},{"issue":"5","key":"9727_CR27","doi-asserted-by":"publisher","first-page":"e20424","DOI":"10.1371\/journal.pone.0020424","volume":"6","author":"C M\u00fchlfeld","year":"2011","unstructured":"M\u00fchlfeld, C., Das, S. K., Heinzel, F. R., Schmidt, A., Post, H., Schauer, S., & Hoefler, G. (2011). Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart. PLoS ONE, 6(5), e20424. https:\/\/doi.org\/10.1371\/journal.pone.0020424","journal-title":"PLoS ONE"},{"issue":"1","key":"9727_CR28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/J.CARDIORES.2006.12.021","volume":"74","author":"P Razeghi","year":"2007","unstructured":"Razeghi, P., Wang, M. E., Youker, K. A., Golfman, L., Stepkowski, S., & Taegtmeyer, H. (2007). Lack of NF-kappaB1 (p105\/p50) attenuates unloading-induced downregulation of PPARalpha and PPARalpha-regulated gene expression in rodent heart. Cardiovascular Research, 74(1), 133\u2013139. https:\/\/doi.org\/10.1016\/J.CARDIORES.2006.12.021","journal-title":"Cardiovascular Research"},{"issue":"3","key":"9727_CR29","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1006\/JMCC.1997.0628","volume":"30","author":"M Gidh-Jain","year":"1998","unstructured":"Gidh-Jain, M., Huang, B., Jain, P., Gick, G., & El-Sherif, N. (1998). Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction. Journal of Molecular and Cellular Cardiology, 30(3), 627\u2013637. https:\/\/doi.org\/10.1006\/JMCC.1997.0628","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"1","key":"9727_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/PHYSREV.00015.2009\/ASSET\/IMAGES\/LARGE\/Z9J0011025330007.JPEG","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010). Myocardial fatty acid metabolism in health and disease. Physiological Reviews, 90(1), 207\u2013258. https:\/\/doi.org\/10.1152\/PHYSREV.00015.2009\/ASSET\/IMAGES\/LARGE\/Z9J0011025330007.JPEG","journal-title":"Physiological Reviews"},{"issue":"8","key":"9727_CR31","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1054\/BJOC.2001.1700","volume":"84","author":"JE Beliz\u00e1rio","year":"2001","unstructured":"Beliz\u00e1rio, J. E., Lorite, M. J., & Tisdale, M. J. (2001). Cleavage of caspases-1, -3, -6, -8 and -9 substrates by proteases in skeletal muscles from mice undergoing cancer cachexia. British Journal of Cancer, 84(8), 1135. https:\/\/doi.org\/10.1054\/BJOC.2001.1700","journal-title":"British Journal of Cancer"},{"issue":"2","key":"9727_CR32","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1006\/BBRC.2000.2462","volume":"270","author":"M Van Royen","year":"2000","unstructured":"Van Royen, M., Carb\u00f3, N., Busquets, S., Alvarez, B., Quinn, L. S., L\u00f3pez-Soriano, F. J., & Argil\u00e9s, J. M. (2000). DNA fragmentation occurs in skeletal muscle during tumor growth: A link with cancer cachexia? Biochemical and Biophysical Research Communications, 270(2), 533\u2013537. https:\/\/doi.org\/10.1006\/BBRC.2000.2462","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"9727_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/J.1349-7006.2001.TB01044.X","volume":"92","author":"O Ishiko","year":"2001","unstructured":"Ishiko, O., Sumi, T., Hirai, K., Honda, K. I., Nakata, S., Yoshida, H., & Ogita, S. (2001). Apoptosis of muscle cells causes weight loss prior to impairment of DNA synthesis in tumor-bearing rabbits. Japanese Journal of Cancer Research: Gann, 92(1), 30\u201335. https:\/\/doi.org\/10.1111\/J.1349-7006.2001.TB01044.X","journal-title":"Japanese Journal of Cancer Research: Gann"},{"issue":"4","key":"9727_CR34","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0092-8674(00)81382-3","volume":"87","author":"J Zha","year":"1996","unstructured":"Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996). Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14\u20133-3 not BCL-X(L). Cell, 87(4), 619\u2013628. https:\/\/doi.org\/10.1016\/S0092-8674(00)81382-3","journal-title":"Cell"},{"issue":"3","key":"9727_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1139\/H09-049","volume":"34","author":"A Zorzano","year":"2009","unstructured":"Zorzano, A. (2009). Regulation of mitofusin-2 expression in skeletal muscle. Applied Physiology, Nutrition, and Metabolism, 34(3), 433\u2013439. https:\/\/doi.org\/10.1139\/H09-049","journal-title":"Applied Physiology, Nutrition, and Metabolism"},{"issue":"11","key":"9727_CR36","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s, J. M., Busquets, S., Stemmler, B., & L\u00f3pez-Soriano, F. J. (2014). Cancer cachexia: Understanding the molecular basis. Nature Reviews Cancer, 14(11), 754\u2013762. https:\/\/doi.org\/10.1038\/nrc3829","journal-title":"Nature Reviews Cancer"},{"key":"9727_CR37","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/(SICI)1097-0215(19961127)68:5","volume":"68","author":"J Fujital","year":"1996","unstructured":"Fujital, J., Tsujinaka, T., Yano, M., Ebisull, C., Saito, H., Katsume, A., & Monden, M. (1996). Anti-interlukin-6 receptor antibody prevents muscle atrophy in colon-26 adenocarcinoma-bearing mice with modulation of lysosomal and ATP-ubiquitin-dependent proteolytic pathways. International Journal of Cancer, 68, 637\u2013643. https:\/\/doi.org\/10.1002\/(SICI)1097-0215(19961127)68:5","journal-title":"International Journal of Cancer"},{"issue":"3","key":"9727_CR38","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3892\/IJO.27.3.855\/HTML","volume":"27","author":"M Figueras","year":"2005","unstructured":"Figueras, M., Busquets, S., Carb\u00f3, N., Almendro, V., Argil\u00e9s, J. M., & L\u00f3pez-Soriano, F. J. (2005). Cancer cachexia results in an increase in TNF-\u03b1 receptor gene expression in both skeletal muscle and adipose tissue. International Journal of Oncology, 27(3), 855\u2013860. https:\/\/doi.org\/10.3892\/IJO.27.3.855\/HTML","journal-title":"International Journal of Oncology"},{"issue":"9","key":"9727_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0024650","volume":"6","author":"JP White","year":"2011","unstructured":"White, J. P., Baynes, J. W., Welle, S. L., Kostek, M. C., Matesic, L. E., Sato, S., & Carson, J. A. (2011). The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the ApcMin\/+ mouse. PLoS ONE, 6(9), e24650. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0024650","journal-title":"PLoS ONE"},{"issue":"2","key":"9727_CR40","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","volume":"56","author":"GC Mel\u00e9ndez","year":"2010","unstructured":"Mel\u00e9ndez, G. C., McLarty, J. L., Levick, S. P., Du, Y., Janicki, J. S., & Brower, G. L. (2010). Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension, 56(2), 225\u2013231. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.109.148635","journal-title":"Hypertension"},{"issue":"11","key":"9727_CR41","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.106.643585","volume":"115","author":"M Sun","year":"2007","unstructured":"Sun, M., Chen, M., Dawood, F., Zurawska, U., Li, J. Y., Parker, T., & Liu, P. P. (2007). Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Circulation, 115(11), 1398\u20131407. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.643585","journal-title":"Circulation"},{"issue":"9","key":"9727_CR42","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/J.BIOCEL.2006.03.015","volume":"38","author":"M Bossola","year":"2006","unstructured":"Bossola, M., Mirabella, M., Ricci, E., Costelli, P., Pacelli, F., Tortorelli, A. P., & Doglietto, G. B. (2006). Skeletal muscle apoptosis is not increased in gastric cancer patients with mild-moderate weight loss. The International Journal of Biochemistry & Cell Biology, 38(9), 1561\u20131570. https:\/\/doi.org\/10.1016\/J.BIOCEL.2006.03.015","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"issue":"5","key":"9727_CR43","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.3892\/ijo.30.5.1239","volume":"30","author":"R Moore-Carrasco","year":"2007","unstructured":"Moore-Carrasco, R., Busquets, S., Almendro, V., Palanki, M., L\u00f3pez-Soriano, F. J., & Argil\u00e9s, J. M. (2007). The AP-1\/NF-\u03baB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia. International Journal of Oncology, 30(5), 1239\u20131245. https:\/\/doi.org\/10.3892\/ijo.30.5.1239","journal-title":"International Journal of Oncology"},{"issue":"5","key":"9727_CR44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/J.CLNU.2007.06.005","volume":"26","author":"S Busquets","year":"2007","unstructured":"Busquets, S., Deans, C., Figueras, M., Moore-Carrasco, R., L\u00f3pez-Soriano, F. J., Fearon, K. C. H., & Argil\u00e9s, J. M. (2007). Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients. Clinical Nutrition (Edinburgh, Scotland), 26(5), 614\u2013618. https:\/\/doi.org\/10.1016\/J.CLNU.2007.06.005","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"issue":"6","key":"9727_CR45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/01.BOR.0000245731.25383.DE","volume":"18","author":"S Ventadour","year":"2006","unstructured":"Ventadour, S., & Attaix, D. (2006). Mechanisms of skeletal muscle atrophy. Current Opinion in Rheumatology, 18(6), 631\u2013635. https:\/\/doi.org\/10.1097\/01.BOR.0000245731.25383.DE","journal-title":"Current Opinion in Rheumatology"},{"issue":"4","key":"9727_CR46","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1161\/01.CIR.87.4.1418","volume":"87","author":"AM Samarel","year":"1993","unstructured":"Samarel, A. M. (1993). Hemodynamic overload and the regulation of myofibrillar protein degradation. Circulation, 87(4), 1418\u20131420. https:\/\/doi.org\/10.1161\/01.CIR.87.4.1418","journal-title":"Circulation"},{"key":"9727_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1152\/PHYSIOLGENOMICS.00165.2004","volume":"20","author":"M Wellner","year":"2005","unstructured":"Wellner, M., Dechend, R., Park, J. K., Shagdarsuren, E., Al-Saadi, N., Kirsch, T., & Muller, D. N. (2005). Cardiac gene expression profile in rats with terminal heart failure and cachexia. Physiological Genomics, 20, 256\u2013267. https:\/\/doi.org\/10.1152\/PHYSIOLGENOMICS.00165.2004","journal-title":"Physiological Genomics"},{"issue":"2","key":"9727_CR48","doi-asserted-by":"publisher","first-page":"H412","DOI":"10.1152\/AJPHEART.2000.278.2.H412","volume":"278","author":"JC Tardiff","year":"2000","unstructured":"Tardiff, J. C., Hewett, T. E., Factor, S. M., Vikstrom, K. L., Robbins, J., & Leinwand, L. A. (2000). Expression of the beta (slow)-isoform of MHC in the adult mouse heart causes dominant-negative functional effects. American Journal of Physiology. Heart and Circulatory Physiology, 278(2), H412. https:\/\/doi.org\/10.1152\/AJPHEART.2000.278.2.H412","journal-title":"American Journal of Physiology. Heart and Circulatory Physiology"},{"issue":"2","key":"9727_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/01.RES.77.2.439","volume":"77","author":"P VanBuren","year":"1995","unstructured":"VanBuren, P., Harris, D. E., Alpert, N. R., & Warshaw, D. M. (1995). Cardiac V1 and V3 myosins differ in their hydrolytic and mechanical activities in vitro. Circulation Research, 77(2), 439\u2013444. https:\/\/doi.org\/10.1161\/01.RES.77.2.439","journal-title":"Circulation Research"},{"issue":"4","key":"9727_CR50","doi-asserted-by":"publisher","first-page":"H466","DOI":"10.1152\/ajpheart.00720.2015","volume":"310","author":"KT Murphy","year":"2016","unstructured":"Murphy, K. T. (2016). The pathogenesis and treatment of cardiac atrophy in cancer cachexia. American Journal of Physiology - Heart and Circulatory Physiology, 310(4), H466\u2013H477. https:\/\/doi.org\/10.1152\/ajpheart.00720.2015","journal-title":"American Journal of Physiology - Heart and Circulatory Physiology"},{"issue":"4","key":"9727_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1164\/RCCM.200910-1487OC","volume":"183","author":"S Levine","year":"2011","unstructured":"Levine, S., Biswas, C., Dierov, J., Barsotti, R., Shrager, J. B., Nguyen, T., & Budak, M. T. (2011). Increased proteolysis, myosin depletion, and atrophic AKT-FOXO signaling in human diaphragm disuse. American Journal of Respiratory and Critical Care Medicine, 183(4), 483\u2013490. https:\/\/doi.org\/10.1164\/RCCM.200910-1487OC","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"44","key":"9727_CR52","doi-asserted-by":"publisher","first-page":"16260","DOI":"10.1073\/pnas.0607795103","volume":"103","author":"M Sandri","year":"2006","unstructured":"Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., & Spiegelman, B. M. (2006). PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription. Proceedings of the National Academy of Sciences of the United States of America, 103(44), 16260\u201316265. https:\/\/doi.org\/10.1073\/pnas.0607795103","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"25","key":"9727_CR53","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1073\/PNAS.251541198","volume":"98","author":"MD Gomes","year":"2001","unstructured":"Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001). Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proceedings of the National Academy of Sciences of the United States of America, 98(25), 14440\u201314445. https:\/\/doi.org\/10.1073\/PNAS.251541198","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5547","key":"9727_CR54","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1126\/SCIENCE.1065874","volume":"294","author":"SC Bodine","year":"2001","unstructured":"Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K. M., Nunez, L., Clarke, B. A., & Glass, D. J. (2001). Identification of ubiquitin ligases required for skeletal muscle atrophy. Science (New York, N.Y.), 294(5547), 1704\u20131708. https:\/\/doi.org\/10.1126\/SCIENCE.1065874","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"9727_CR55","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ICB.1978.28","volume":"56","author":"CA Earl","year":"1978","unstructured":"Earl, C. A., Laurent, G. J., Everett, A. W., Bonnin, C. M., & Sparrow, M. P. (1978). Turnover rates of muscle protein in cardiac and skeletal muscles of dog, fowl, rat and mouse: Turnover rate related to muscle function. The Australian Journal of Experimental Biology and Medical Science, 56(3), 265\u2013277. https:\/\/doi.org\/10.1038\/ICB.1978.28","journal-title":"The Australian Journal of Experimental Biology and Medical Science"},{"issue":"3","key":"9727_CR56","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1006\/BBRC.2000.3609","volume":"276","author":"Z Liu","year":"2000","unstructured":"Liu, Z., Miers, W., Wei, L., & Barrett, E. (2000). The ubiquitin-proteasome proteolytic pathway in heart vs skeletal muscle: Effects of acute diabetes. Biochemical and Biophysical Research Communications, 276(3), 1255\u20131260. https:\/\/doi.org\/10.1006\/BBRC.2000.3609","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"9727_CR57","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1054\/bjoc.2001.1696","volume":"84","author":"P Costelli","year":"2001","unstructured":"Costelli, P., De Tullio, R., Baccino, F. M., & Melloni, E. (2001). Activation of Ca2+-dependent proteolysis in skeletal muscle and heart in cancer cachexia. British Journal of Cancer, 84(7), 946\u2013950. https:\/\/doi.org\/10.1054\/bjoc.2001.1696","journal-title":"British Journal of Cancer"},{"issue":"1","key":"9727_CR58","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00000658-200101000-00003","volume":"233","author":"PO Hasselgren","year":"2001","unstructured":"Hasselgren, P. O., & Fischer, J. E. (2001). Muscle cachexia: Current concepts of intracellular mechanisms and molecular regulation. Annals of Surgery, 233(1), 9\u201317. https:\/\/doi.org\/10.1097\/00000658-200101000-00003","journal-title":"Annals of Surgery"},{"issue":"1","key":"9727_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1242\/DMM.010389","volume":"6","author":"P Bonaldo","year":"2013","unstructured":"Bonaldo, P., & Sandri, M. (2013). Cellular and molecular mechanisms of muscle atrophy. Disease Models & Mechanisms, 6(1), 25\u201339. https:\/\/doi.org\/10.1242\/DMM.010389","journal-title":"Disease Models & Mechanisms"},{"issue":"1","key":"9727_CR60","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/J.CELL.2007.12.018","volume":"132","author":"B Levine","year":"2008","unstructured":"Levine, B., & Kroemer, G. (2008). Autophagy in the pathogenesis of disease. Cell, 132(1), 27\u201342. https:\/\/doi.org\/10.1016\/J.CELL.2007.12.018","journal-title":"Cell"},{"issue":"6","key":"9727_CR61","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/J.CMET.2007.11.001","volume":"6","author":"C Mammucari","year":"2007","unstructured":"Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., & Sandri, M. (2007). FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metabolism, 6(6), 458\u2013471. https:\/\/doi.org\/10.1016\/J.CMET.2007.11.001","journal-title":"Cell Metabolism"},{"issue":"5","key":"9727_CR62","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1080\/15548627.2015.1038016","volume":"11","author":"R Huang","year":"2015","unstructured":"Huang, R., & Liu, W. (2015). Identifying an essential role of nuclear LC3 for autophagy. Autophagy, 11(5), 852. https:\/\/doi.org\/10.1080\/15548627.2015.1038016","journal-title":"Autophagy"},{"key":"9727_CR63","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1042\/BJ2750165","volume":"275","author":"SS Wing","year":"1991","unstructured":"Wing, S. S., Chiang, H. L., Goldberg, A. L., & Dice, J. F. (1991). Proteins containing peptide sequences related to Lys-Phe-Glu-Arg-Gln are selectively depleted in liver and heart, but not skeletal muscle, of fasted rats. The Biochemical Journal, 275, 165\u2013169. https:\/\/doi.org\/10.1042\/BJ2750165","journal-title":"The Biochemical Journal"},{"issue":"24","key":"9727_CR64","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.107.763870","volume":"117","author":"P Tannous","year":"2008","unstructured":"Tannous, P., Zhu, H., Nemchenko, A., Berry, J. M., Johnstone, J. L., Shelton, J. M., & Hill, J. A. (2008). Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation, 117(24), 3070\u20133078. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.107.763870","journal-title":"Circulation"},{"issue":"5","key":"9727_CR65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/NM1574","volume":"13","author":"A Nakai","year":"2007","unstructured":"Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., & Otsu, K. (2007). The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nature Medicine, 13(5), 619\u2013624. https:\/\/doi.org\/10.1038\/NM1574","journal-title":"Nature Medicine"},{"issue":"4","key":"9727_CR66","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1172\/JCI64398","volume":"123","author":"J Zhou","year":"2013","unstructured":"Zhou, J., Freeman, T. A., Ahmad, F., Shang, X., Mangano, E., Gao, E., & Force, T. (2013). GSK-3\u03b1 is a central regulator of age-related pathologies in mice. The Journal of Clinical Investigation, 123(4), 1821\u20131832. https:\/\/doi.org\/10.1172\/JCI64398","journal-title":"The Journal of Clinical Investigation"},{"issue":"1","key":"9727_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2044-5040-1-4\/FIGURES\/4","volume":"1","author":"S Schiaffino","year":"2011","unstructured":"Schiaffino, S., & Mammucari, C. (2011). Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: Insights from genetic models. Skeletal Muscle, 1(1), 1\u201314. https:\/\/doi.org\/10.1186\/2044-5040-1-4\/FIGURES\/4","journal-title":"Skeletal Muscle"},{"key":"9727_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172657","volume":"862","author":"BM Patel","year":"2019","unstructured":"Patel, B. M., & Goyal, R. K. (2019). Liver and insulin resistance: New wine in old bottle!!! European Journal of Pharmacology, 862, 172657. https:\/\/doi.org\/10.1016\/j.ejphar.2019.172657","journal-title":"European Journal of Pharmacology"},{"key":"9727_CR69","doi-asserted-by":"publisher","DOI":"10.1177\/0960327112450885","author":"BR Goyal","year":"2013","unstructured":"Goyal, B. R., & Mehta, A. A. (2013). Diabetic cardiomyopathy: Pathophysiological mechanisms and cardiac dysfuntion. Human and Experimental Toxicology. https:\/\/doi.org\/10.1177\/0960327112450885","journal-title":"Human and Experimental Toxicology"},{"issue":"1","key":"9727_CR70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s43440-020-00179-y","volume":"73","author":"T Masi","year":"2021","unstructured":"Masi, T., & Patel, B. M. (2021). Altered glucose metabolism and insulin resistance in cancer-induced cachexia: A sweet poison. Pharmacological Reports, 73(1), 17\u201330. https:\/\/doi.org\/10.1007\/s43440-020-00179-y","journal-title":"Pharmacological Reports"},{"issue":"4","key":"9727_CR71","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1074\/JBC.M407517200","volume":"280","author":"E Latres","year":"2005","unstructured":"Latres, E., Amini, A. R., Amini, A. A., Griffiths, J., Martin, F. J., Wei, Y., & Glass, D. J. (2005). Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase\/Akt\/mammalian target of rapamycin (PI3K\/Akt\/mTOR) pathway. The Journal of Biological Chemistry, 280(4), 2737\u20132744. https:\/\/doi.org\/10.1074\/JBC.M407517200","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"9727_CR72","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/BJC.1993.126","volume":"67","author":"KL Smith","year":"1993","unstructured":"Smith, K. L., & Tisdale, M. J. (1993). Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. British Journal of Cancer, 67(4), 680\u2013685. https:\/\/doi.org\/10.1038\/BJC.1993.126","journal-title":"British Journal of Cancer"},{"issue":"51","key":"9727_CR73","doi-asserted-by":"publisher","first-page":"49831","DOI":"10.1074\/JBC.M204291200","volume":"277","author":"B Langley","year":"2002","unstructured":"Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., & Kambadur, R. (2002). Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. The Journal of Biological Chemistry, 277(51), 49831\u201349840. https:\/\/doi.org\/10.1074\/JBC.M204291200","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"9727_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/J.1472-8206.2010.00814.X","volume":"25","author":"SV Bhadada","year":"2011","unstructured":"Bhadada, S. V., Goyal, B. R., & Patel, M. M. (2011). Angiogenic targets for potential disorders. Fundamental & Clinical Pharmacology, 25(1), 29\u201347. https:\/\/doi.org\/10.1111\/J.1472-8206.2010.00814.X","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"9727_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/J.IJCARD.2017.03.153","volume":"238","author":"J Ishida","year":"2017","unstructured":"Ishida, J., Konishi, M., Saitoh, M., Anker, M., Anker, S. D., & Springer, J. (2017). Myostatin signaling is up-regulated in female patients with advanced heart failure. International Journal of Cardiology, 238, 37\u201342. https:\/\/doi.org\/10.1016\/J.IJCARD.2017.03.153","journal-title":"International Journal of Cardiology"},{"issue":"3","key":"9727_CR76","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.109.882068","volume":"121","author":"J Heineke","year":"2010","unstructured":"Heineke, J., Auger-Messier, M., Xu, J., Sargent, M., York, A., Welle, S., & Molkentin, J. D. (2010). Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation, 121(3), 419. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.882068","journal-title":"Circulation"},{"key":"9727_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/S13395-016-0098-2","author":"S Hatakeyama","year":"2016","unstructured":"Hatakeyama, S., Summermatter, S., Jourdain, M., Melly, S., Minetti, G. C., & Lach-Trifilieff, E. (2016). ActRII blockade protects mice from cancer cachexia and prolongs survival in the presence of anti-cancer treatments. Skeletal Muscle. https:\/\/doi.org\/10.1186\/S13395-016-0098-2","journal-title":"Skeletal Muscle"},{"issue":"4","key":"9727_CR78","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou, X., Wang, J. L., Lu, J., Song, Y., Kwak, K. S., Jiao, Q., & Han, H. Q. (2010). Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell, 142(4), 531\u2013543. https:\/\/doi.org\/10.1016\/j.cell.2010.07.011","journal-title":"Cell"},{"key":"9727_CR79","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.lfs.2016.11.033","volume":"170","author":"HJ Patel","year":"2017","unstructured":"Patel, H. J., & Patel, B. M. (2017). TNF-\u03b1 and cancer cachexia: Molecular insights and clinical implications. Life Sciences, 170, 56\u201363. https:\/\/doi.org\/10.1016\/j.lfs.2016.11.033","journal-title":"Life Sciences"},{"key":"9727_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/J.LFS.2021.119329","volume":"274","author":"V Bora","year":"2021","unstructured":"Bora, V., & Patel, B. M. (2021). Investigation into the role of anti-diabetic agents in cachexia associated with metastatic cancer. Life Sciences, 274, 119329. https:\/\/doi.org\/10.1016\/J.LFS.2021.119329","journal-title":"Life Sciences"},{"issue":"14","key":"9727_CR81","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2174\/1389200220666190816162658","volume":"20","author":"DT Dave","year":"2019","unstructured":"Dave, D. T., & Patel, B. M. (2019). Mitochondrial metabolism in cancer cachexia: novel drug target. Current Drug Metabolism, 20(14), 1141\u20131153. https:\/\/doi.org\/10.2174\/1389200220666190816162658","journal-title":"Current Drug Metabolism"},{"issue":"3","key":"9727_CR82","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/ars.2009.2818","volume":"12","author":"J Marin-Corral","year":"2010","unstructured":"Marin-Corral, J., Fontes, C. C., Pascual-Guardia, S., Sanchez, F., Olivan, M., Argil\u00e9s, J. M., & Barreiro, E. (2010). Redox balance and carbonylated proteins in limb and heart muscles of cachectic rats. Antioxidants and Redox Signaling, 12(3), 365\u2013380. https:\/\/doi.org\/10.1089\/ars.2009.2818","journal-title":"Antioxidants and Redox Signaling"},{"issue":"3","key":"9727_CR83","doi-asserted-by":"publisher","first-page":"18005","DOI":"10.1371\/JOURNAL.PONE.0018005","volume":"6","author":"JM Velez","year":"2011","unstructured":"Velez, J. M., Miriyala, S., Nithipongvanitch, R., Noel, T., Plabplueng, C. D., Oberley, T., & St Clair, D. K. (2011). p53 regulates oxidative stress-mediated retrograde signaling: A novel mechanism for chemotherapy-induced cardiac injury. PLoS ONE, 6(3), 18005. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0018005","journal-title":"PLoS ONE"},{"issue":"8","key":"9727_CR84","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1113\/JPHYSIOL.2014.286518","volume":"593","author":"K Min","year":"2015","unstructured":"Min, K., Kwon, O. S., Smuder, A. J., Wiggs, M. P., Sollanek, K. J., Christou, D. D., & Powers, S. K. (2015). Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy. The Journal of Physiology, 593(8), 2017\u20132036. https:\/\/doi.org\/10.1113\/JPHYSIOL.2014.286518","journal-title":"The Journal of Physiology"},{"issue":"5","key":"9727_CR85","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3109\/10641963.2013.827699","volume":"36","author":"BM Patel","year":"2014","unstructured":"Patel, B. M., & Bhadada, S. V. (2014). Type 2 diabetes-induced cardiovascular complications: Comparative evaluation of spironolactone, atenolol, metoprolol, ramipril and perindopril. Clinical and Experimental Hypertension, 36(5), 340\u2013347. https:\/\/doi.org\/10.3109\/10641963.2013.827699","journal-title":"Clinical and Experimental Hypertension"},{"issue":"7","key":"9727_CR86","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1007\/s00520-016-3222-2","volume":"24","author":"Y Zheng","year":"2016","unstructured":"Zheng, Y., Chen, H., Li, X., & Sun, Y. (2016). Pay attention to cardiac remodeling in cancer cachexia. Supportive Care in Cancer, 24(7), 3253\u20133259. https:\/\/doi.org\/10.1007\/s00520-016-3222-2","journal-title":"Supportive Care in Cancer"},{"issue":"5","key":"9727_CR87","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/ijc.28128","volume":"133","author":"KT Murphy","year":"2013","unstructured":"Murphy, K. T., Chee, A., Trieu, J., Naim, T., & Lynch, G. S. (2013). Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia. International Journal of Cancer, 133(5), 1234\u20131246. https:\/\/doi.org\/10.1002\/ijc.28128","journal-title":"International Journal of Cancer"},{"issue":"11","key":"9727_CR88","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1177\/0960327112446817","volume":"31","author":"BM Patel","year":"2012","unstructured":"Patel, B. M., Agarwal, S. S., & Bhadada, S. V. (2012). Perindopril protects against streptozotocin-induced hyperglycemic myocardial damage\/alterations. Human and Experimental Toxicology, 31(11), 1132\u20131143. https:\/\/doi.org\/10.1177\/0960327112446817","journal-title":"Human and Experimental Toxicology"},{"key":"9727_CR89","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.yjmcc.2015.05.007","volume":"85","author":"SCW Stevens","year":"2015","unstructured":"Stevens, S. C. W., Velten, M., Youtz, D. J., Clark, Y., Jing, R., Reiser, P. J., & Wold, L. E. (2015). Losartan treatment attenuates tumor-induced myocardial dysfunction. Journal of Molecular and Cellular Cardiology, 85, 37\u201347. https:\/\/doi.org\/10.1016\/j.yjmcc.2015.05.007","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"1\u20132","key":"9727_CR90","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11010-008-9772-y","volume":"314","author":"BR Goyal","year":"2008","unstructured":"Goyal, B. R., Mesariya, P., Goyal, R. K., & Mehta, A. A. (2008). Effect of telmisartan on cardiovascular complications associated with streptozotocin diabetic rats. Molecular and Cellular Biochemistry, 314(1\u20132), 123\u2013131. https:\/\/doi.org\/10.1007\/s11010-008-9772-y","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"4","key":"9727_CR91","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S1734-1140(11)70611-9","volume":"63","author":"BR Goyal","year":"2011","unstructured":"Goyal, B. R., Parmar, K., Goyal, R. K., & Mehta, A. A. (2011). Beneficial role of telmisartan on cardiovascular complications associated with STZ-induced type 2 diabetes in rats. Pharmacological Reports, 63(4), 956\u2013966. https:\/\/doi.org\/10.1016\/S1734-1140(11)70611-9","journal-title":"Pharmacological Reports"},{"key":"9727_CR92","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.lfs.2016.04.029","volume":"154","author":"S Sukumaran","year":"2016","unstructured":"Sukumaran, S., Patel, H. J., & Patel, B. M. (2016). Evaluation of role of telmisartan in combination with 5-fluorouracil in gastric cancer cachexia. Life Sciences, 154, 15\u201323. https:\/\/doi.org\/10.1016\/j.lfs.2016.04.029","journal-title":"Life Sciences"},{"key":"9727_CR93","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/642848","author":"BM Patel","year":"2013","unstructured":"Patel, B. M., & Damle, D. (2013). Combination of telmisartan with cisplatin controls oral cancer cachexia in rats. BioMed Research International. https:\/\/doi.org\/10.1155\/2013\/642848","journal-title":"BioMed Research International"},{"issue":"2","key":"9727_CR94","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/ac.67.2.2154211","volume":"67","author":"BR Goyal","year":"2012","unstructured":"Goyal, B. R., & Mehta, A. A. (2012). Beneficial role of spironolactone, telmisartan and their combination on isoproterenol-induced cardiac hypertrophy. Acta Cardiologica, 67(2), 203\u2013211. https:\/\/doi.org\/10.1080\/ac.67.2.2154211","journal-title":"Acta Cardiologica"},{"issue":"1\u20133","key":"9727_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.EJPHAR.2012.09.034","volume":"697","author":"BM Patel","year":"2012","unstructured":"Patel, B. M., & Mehta, A. A. (2012). Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases. European Journal of Pharmacology, 697(1\u20133), 1\u201312. https:\/\/doi.org\/10.1016\/J.EJPHAR.2012.09.034","journal-title":"European Journal of Pharmacology"},{"issue":"8","key":"9727_CR96","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1055\/s-0033-1345168","volume":"121","author":"BM Patel","year":"2013","unstructured":"Patel, B. M., Kakadiya, J., Goyal, R. K., & Mehta, A. A. (2013). Effect of spironolactone on cardiovascular complications associated with type-2 diabetes in rats. Experimental and Clinical Endocrinology and Diabetes, 121(8), 441\u2013447. https:\/\/doi.org\/10.1055\/s-0033-1345168","journal-title":"Experimental and Clinical Endocrinology and Diabetes"},{"issue":"6","key":"9727_CR97","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/FJC.0b013e3181be75cc","volume":"54","author":"BR Goyal","year":"2009","unstructured":"Goyal, B. R., Solanki, N., Goyal, R. K., & Mehta, A. A. (2009). Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes. Journal of Cardiovascular Pharmacology, 54(6), 502\u2013509. https:\/\/doi.org\/10.1097\/FJC.0b013e3181be75cc","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"4","key":"9727_CR98","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13539-014-0153-y","volume":"5","author":"M Toledo","year":"2014","unstructured":"Toledo, M., Springer, J., Busquets, S., Tschirner, A., L\u00f3pez-Soriano, F. J., Anker, S. D., & Argil\u00e9s, J. M. (2014). Formoterol in the treatment of experimental cancer cachexia: Effects on heart function. Journal of Cachexia, Sarcopenia and Muscle, 5(4), 315\u2013320. https:\/\/doi.org\/10.1007\/s13539-014-0153-y","journal-title":"Journal of Cachexia, Sarcopenia and Muscle"},{"issue":"2","key":"9727_CR99","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.pharep.2014.02.004","volume":"66","author":"BM Patel","year":"2014","unstructured":"Patel, B. M., & Desai, V. J. (2014). Beneficial role of tamoxifen in experimentally induced cardiac hypertrophy. Pharmacological Reports, 66(2), 264\u2013272. https:\/\/doi.org\/10.1016\/j.pharep.2014.02.004","journal-title":"Pharmacological Reports"},{"issue":"10","key":"9727_CR100","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1139\/cjpp-2013-0348","volume":"92","author":"N Rayabarapu","year":"2014","unstructured":"Rayabarapu, N., & Patel, B. M. (2014). Beneficial role of tamoxifen in isoproterenol-induced myocardial infarction. Canadian Journal of Physiology and Pharmacology, 92(10), 849\u2013857. https:\/\/doi.org\/10.1139\/cjpp-2013-0348","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"9727_CR101","volume-title":"Oxidative stress in heart diseases","author":"B Patel","year":"2019","unstructured":"Patel, B. (2019). Histone deacetylases and oxidative stress: Role in diabetic cardiomyopathy. In H. Aggarwal, B. N. Kanuri, & M. Dikshit (Eds.), Oxidative stress in heart diseases. New York: Springer."},{"key":"9727_CR102","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejps.2018.05.026","volume":"121","author":"MM Patel","year":"2018","unstructured":"Patel, M. M., & Patel, B. M. (2018). Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition. European Journal of Pharmaceutical Sciences, 121, 188\u2013199. https:\/\/doi.org\/10.1016\/j.ejps.2018.05.026","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"1","key":"9727_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12012-017-9406-2","volume":"18","author":"BM Patel","year":"2018","unstructured":"Patel, B. M. (2018). Sodium butyrate controls cardiac hypertrophy in experimental models of rats. Cardiovascular Toxicology, 18(1), 1\u20138. https:\/\/doi.org\/10.1007\/s12012-017-9406-2","journal-title":"Cardiovascular Toxicology"},{"issue":"1","key":"9727_CR104","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejphar.2014.01.063","volume":"728","author":"BM Patel","year":"2014","unstructured":"Patel, B. M., Raghunathan, S., & Porwal, U. (2014). Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus. European Journal of Pharmacology, 728(1), 128\u2013134. https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.063","journal-title":"European Journal of Pharmacology"},{"issue":"3","key":"9727_CR105","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1139\/cjpp-2016-0542","volume":"95","author":"S Raghunathan","year":"2016","unstructured":"Raghunathan, S., Goyal, R. K., & Patel, B. M. (2016). Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy. Canadian Journal of Physiology and Pharmacology, 95(3), 260\u2013267. https:\/\/doi.org\/10.1139\/cjpp-2016-0542","journal-title":"Canadian Journal of Physiology and Pharmacology"},{"key":"9727_CR106","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.biopha.2017.10.137","volume":"97","author":"S Rabadiya","year":"2018","unstructured":"Rabadiya, S., Bhadada, S., Dudhrejiya, A., Vaishnav, D., & Patel, B. (2018). Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors. Biomedicine and Pharmacotherapy, 97, 919\u2013927. https:\/\/doi.org\/10.1016\/j.biopha.2017.10.137","journal-title":"Biomedicine and Pharmacotherapy"},{"key":"9727_CR107","doi-asserted-by":"publisher","first-page":"204062231986269","DOI":"10.1177\/2040622319862697","volume":"10","author":"X Lyu","year":"2019","unstructured":"Lyu, X., Hu, M., Peng, J., Zhang, X., & Sanders, Y. Y. (2019). HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis. Therapeutic Advances in Chronic Disease, 10, 2040622319862697. https:\/\/doi.org\/10.1177\/2040622319862697","journal-title":"Therapeutic Advances in Chronic Disease"},{"key":"9727_CR108","doi-asserted-by":"publisher","DOI":"10.3389\/FCVM.2021.658900","author":"P Papazoglou","year":"2021","unstructured":"Papazoglou, P., Peng, L., & Sachinidis, A. (2021). Epigenetic mechanisms involved in the cardiovascular toxicity of anticancer drugs. Frontiers in Cardiovascular Medicine. https:\/\/doi.org\/10.3389\/FCVM.2021.658900","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"4","key":"9727_CR109","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1016\/j.ijcard.2013.04.150","volume":"168","author":"S Palus","year":"2013","unstructured":"Palus, S., Von Haehling, S., Flach, V. C., Tschirner, A., Doehner, W., Anker, S. D., & Springer, J. (2013). Simvastatin reduces wasting and improves cardiac function as well as outcome in experimental cancer cachexia. International Journal of Cardiology, 168(4), 3412\u20133418. https:\/\/doi.org\/10.1016\/j.ijcard.2013.04.150","journal-title":"International Journal of Cardiology"},{"issue":"9","key":"9727_CR110","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.nut.2013.12.005","volume":"30","author":"K Trobec","year":"2014","unstructured":"Trobec, K., Palus, S., Tschirner, A., von Haehling, S., Doehner, W., Lainscak, M., Anker, S. D., & Springer, J. (2014). Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia. Nutrition, 30(9), 1069\u20131075. https:\/\/doi.org\/10.1016\/j.nut.2013.12.005","journal-title":"Nutrition"},{"issue":"8","key":"9727_CR111","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00380-015-0724-7","volume":"31","author":"T Hashikata","year":"2016","unstructured":"Hashikata, T., Yamaoka-Tojo, M., Kakizaki, R., Nemoto, T., Fujiyoshi, K., Namba, S., Kitasato, L., Hashimoto, T., Kameda, R., Maekawa, E., Shimohama, T., & Ako, J. (2016). Teneligliptin improves left ventricular diastolic function and endothelial function in patients with diabetes. Heart and Vessels, 31(8), 1303\u20131310. https:\/\/doi.org\/10.1007\/s00380-015-0724-7","journal-title":"Heart and Vessels"},{"issue":"5","key":"9727_CR112","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/01.HYP.33.5.1135","volume":"33","author":"MS Muntzel","year":"1999","unstructured":"Muntzel, M. S., Hamidou, I., & Barrett, S. (1999). Metformin attenuates salt-induced hypertension in spontaneously hypertensive rats. Hypertension, 33(5), 1135\u20131140. https:\/\/doi.org\/10.1161\/01.HYP.33.5.1135","journal-title":"Hypertension"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-022-09727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-022-09727-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-022-09727-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T13:12:54Z","timestamp":1645881174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-022-09727-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["9727"],"URL":"https:\/\/doi.org\/10.1007\/s12012-022-09727-9","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No financial or commercial relationships were involved in the construction of this manuscript and the authors declare no conflict of interest involved in this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}